55.93 USD
↗ 0.53 (0.96%)AT CLOSE (03:59 PM EST)
Axogen, Inc. Common Stock
AXGNNASDAQ • USD
55.50
↘ 0.43 (0.77%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
55.50
↘ 0.43 (0.77%)
Market: CLOSED
Axogen, Inc. Common Stock (AXGN) trades at $55.93 per share. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Strong Buy" and "Buy" respectively. Notable factors include a robust Altman Z-Score, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Nov 13, 2026.
Open?$55.88
High?$57.46
Low?$55.01
Prev. Close?$55.40
Volume?1.4M
Avg. Volume?1.9M
VWAP?$56.20
Rel. Volume?0.72x
Bid / Ask
Bid?$49.60 × 100
Ask?$64.20 × 300
Spread?$14.60
Midpoint?$56.90
Valuation & Ratios
Market Cap?3.3B
Shares Out?59.7M
Float?50.4M
Float %?93.8%
P/E Ratio?N/A
P/B Ratio?6.73
EPS?-$0.53
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
Employees
622
Market Cap
3.3B
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Website
Listed
1986-12-17
Address
13631 PROGRESS BLVD.
ALACHUA, FL 32615
Phone: (386) 462-6817
ALACHUA, FL 32615
Phone: (386) 462-6817
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?100
Momentum?83
Short Sent.?50
Piotroski F-Score?5/9Mixed
Altman Z-Score?37.41Safe
Confidence?67%Moderate
Short InterestHigh
Short % of Float?13.86%High
Short Interest?7.0M
Days to Cover?3.3
Free Float50.4M
Avg Daily Volume2.1M
Settlement Date2026-10-30
Financial Health
Current Ratio?12.02Strong
Quick Ratio?10.67Strong
Cash Ratio?9.02Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score53/100
P/E?N/A▾
P/B?6.73FAIR▾
Peers100
S&P28
P/S?12.52HIGH▾
Peers100
S&P3
P/FCF?151.6PRICEY▾
Peers100
S&P3
EV/EBITDA?-432.6CHEAP▾
S&P97
EV/Sales?11.28HIGH▾
Peers100
S&P8
Returns & Efficiency
ROE?-6.4%WEAK▾
S&P10
ROA?-5.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$22.0M
Enterprise Value?$3.0B
Fundamentals ratios updated end of day